1. Home
  2. FNF vs NBIX Comparison

FNF vs NBIX Comparison

Compare FNF & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FNF Group of Fidelity National Financial Inc.

FNF

FNF Group of Fidelity National Financial Inc.

N/A

Current Price

$48.79

Market Cap

13.7B

Sector

Finance

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$150.77

Market Cap

13.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNF
NBIX
Founded
1847
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
13.2B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
FNF
NBIX
Price
$48.79
$150.77
Analyst Decision
Buy
Strong Buy
Analyst Count
2
22
Target Price
$60.50
$180.91
AVG Volume (30 Days)
1.5M
1.4M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
41.95
EPS
1.98
3.30
Revenue
$14,445,000,000.00
$161,626,000.00
Revenue This Year
$10.90
$24.73
Revenue Next Year
$5.44
$13.14
P/E Ratio
$24.73
$45.72
Revenue Growth
5.58
977.51
52 Week Low
$42.78
$122.14
52 Week High
$61.40
$186.12

Technical Indicators

Market Signals
Indicator
FNF
NBIX
Relative Strength Index (RSI) 44.61 32.48
Support Level $48.08 $125.85
Resistance Level $48.89 $160.08
Average True Range (ATR) 1.41 6.30
MACD -0.57 -2.48
Stochastic Oscillator 20.43 0.98

Price Performance

Historical Comparison
FNF
NBIX

About FNF FNF Group of Fidelity National Financial Inc.

Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: